Progenics Pharmaceuticals to Announce and Host a Conference Call to Discuss Top Line Results from Phase 3 CONDOR Trial of PyL™ in Prostate Cancer on Monday, December 23rd

Pat Purcell
Meeting Engagement

Paul Theisen
Patient Acquisition

Stacey Gandler
Brand Nourishment

Matt Turner
Patient Affordability

Brenda Snow
Authentic Patient Voice

Daniel Sontupe
Market Access

Liz Kane
Impactful Strategy

Matthew Durham
Omnidynamic Marketing

Amy Giles
Increasing Engagement

Bud Bilanich
Success Coach

Joey Cohen
Medication Adherence

Suma Ramadas, PhD
Medical Affairs

David Linetsky
Point-of-Care Marketing

Frank Burrell
Scientific Storytelling